ipilimumab

Ligand id: 6888

Name: ipilimumab

Classification
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (FDA and EMA (2011))
International Nonproprietary Names
INN number INN
8568 ipilimumab
Synonyms
MDX-010 | MDX-101 | MDX-CTLA-4 | Yervoy®
Database Links
Specialist databases
IMGT/mAb-DB 180
Other databases
PubChem SID 178103470
Search PubMed clinical trials ipilimumab
Search PubMed titles ipilimumab
Search PubMed titles/abstracts ipilimumab
Wikipedia Ipilimumab
Comments
Ipilimumab is an anti-CTLA-4 monoclonal antibody. It is likely the subject of patent WO2001014424 [3], as antibody 10D1 which was investigated further, claimed in patent EP1503794 [1]. Ipilimumab is an immune checkpoint inhibitor.